糖尿病与体能状态预测重度持续性放射性直肠炎:STELLAR试验长期内镜发现
本研究对STELLAR研究中74例局部进展期直肠癌新辅助治疗后保肛手术患者进行长期内镜随访,按Vienna直肠镜评分评估黏膜损伤。糖尿病是重度和持续性重度放射性直肠炎的独立危险因素,ECOG体能状态1预测持续性重度损伤。
核心结论
- 糖尿病与体能状态下降是重度和持续性内镜损伤的强独立预测因素,支持对高危患者进行风险分层管理和定制化监测。
研究设计与样本
- STELLAR研究(NCT02533271)的二次分析,纳入74例局部进展期直肠癌新辅助治疗后保肛手术患者,其中39例接受短程放疗/全程新辅助治疗(TNT),35例接受长程放化疗(CRT)。
- 进行系统性内镜随访(>2年),采用Vienna直肠镜评分(VRS)对黏膜损伤分级,多因素分析识别重度(VRS≥3)和持续性重度放射性直肠炎的危险因素。
主要发现
- 内镜严重程度在放疗后2年达峰;TNT组观察到明显的恢复趋势,而CRT组未观察到。
关键数值与推荐
- 重度放射性直肠炎定义为VRS≥3。
临床怎么用
- 对合并糖尿病或ECOG体能状态1的直肠癌放疗患者,应加强内镜监测和预防策略。
- 短程放疗/TNT未增加重度放射性直肠炎风险,且显示有利的恢复模式。
局限性
- 本文为二次分析,样本量74例,部分比较可能效能不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To characterize the long-term endoscopic natural history of chronic radiation proctitis (CRP) and identify predictors of severe lesions in patients with locally advanced rectal cancer from the STELLAR study (NCT02533271) . METHODS AND MATERIALS: This secondary analysis included 74 patients with locally advanced rectal cancer undergoing anal-preserving surgery after neoadjuvant therapy (39: short-course radiation therapy/total neoadjuvant therapy [TNT] and 35: long-course chemoradiation therapy [CRT]). Systematic endoscopic follow-up (>2 years) was performed, with mucosal damage graded by the Vienna Rectoscopy Score (VRS). Multivariate analyses identified factors for severe (VRS ≥3) and persistent severe CRP. RESULTS: The incidence of VRS ≥3 CRP was 33.3% (TNT) versus 20.0% (CRT) (P = .197). Endoscopic severity peaked at 2 years after radiation. A distinct recovery trend was observed in the TNT group, but not in the CRT group. Diabetes mellitus was an independent risk factor for both severe CRP (hazard ratio [HR], 5.46; 95% CI, 1.25-23.89; P = .024) and persistent severe CRP (HR, 6.09; 95% CI, 1.23-30.23; P = .027). Eastern Cooperative Oncology Group performance status 1 predicted persistent severe CRP (HR, 8.81; 95% CI, 1.50-51.68; P = .016). DISCUSSION: Hypofractionated radiation therapy (TNT) did not increase severe CRP risk and showed a favorable recovery pattern. Diabetes and reduced performance status are strong, independent predictors of severe and persistent endoscopic injury, enabling risk-stratified patient management. These findings support tailored surveillance and preventive strategies for high-risk individuals.
引用
- Wang N, Xu T, Li H, et al. Diabetes and Performance Status Predict Severe, Persistent Radiation Proctitis: Long-Term Endoscopic Findings From STELLAR Trial. Int J Radiat Oncol Biol Phys. 2026. PMID: 42142768. doi:10.1016/j.ijrobp.2026.05.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。